77 filings
8-K
SRRK
Scholar Rock Holding Corp
24 Jun 24
Regulation FD Disclosure
7:13am
8-K
SRRK
Scholar Rock Holding Corp
3 Jun 24
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
4:25pm
8-K
SRRK
Scholar Rock Holding Corp
22 May 24
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
8:30am
8-K
SRRK
Scholar Rock Holding Corp
14 May 24
Entry into a Material Definitive Agreement
7:15am
8-K
SRRK
Scholar Rock Holding Corp
7 May 24
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
7:20am
8-K
wcavbdv4
19 Mar 24
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
7:07am
8-K
topro
15 Feb 24
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
8:57am
8-K
lny74f
8 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
gb4bk6ec
7 Nov 23
Results of Operations and Financial Condition
7:15am
8-K
3zaseb
12 Oct 23
Scholar Rock Announces Proposed Public Offering of Common Stock
5:02pm
8-K
ym9r7jbhl
11 Oct 23
Scholar Rock TO ADVANCE ANTIMYOSTATIN PROGRAM to develop novel therapies for CARDIOMETABOLIC DISORDERS
4:48pm
8-K
m8s8x 7x16i7odlk0tb
9 Aug 23
Results of Operations and Financial Condition
4:16pm
8-K
s0eokezfxocht n9c3
30 Jun 23
Regulation FD Disclosure
11:04am
8-K
w86h os7v
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
hq3yj1
9 May 23
Results of Operations and Financial Condition
7:30am
8-K
aissg
10 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
qv7 cgzt3q2
10 Mar 23
Regulation FD Disclosure
6:39pm
8-K
n0sgnszl y5cvb
7 Mar 23
Results of Operations and Financial Condition
7:50am
8-K
regn hfrpkvc21raiv
9 Jan 23
Regulation FD Disclosure
8:01am
8-K
nqj7ly
14 Nov 22
Results of Operations and Financial Condition
8:00am